[HTML] nature.com

[HTML][HTML] Identification of SARS-CoV-2 entry inhibitors among already approved drugs

L Yang, R Pei, H Li, X Ma, Y Zhou, F Zhu… - Acta Pharmacologica …, 2021 - nature.com
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …
被引用次数：88 相关文章
[HTML] nih.gov

[HTML][HTML] Identification of SARS-CoV-2 entry inhibitors among already approved drugs

L Yang, R Pei, H Li, X Ma, Y Zhou, F Zhu… - Acta Pharmacologica …, 2021 - ncbi.nlm.nih.gov
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …
[PDF] researchgate.net

[PDF][PDF] Identification of SARS-CoV-2 entry inhibitors among already approved drugs

L Yang, R Pei, H Li, X Ma, Y Zhou, F Zhu, P He, W Tang… - 2020 - researchgate.net
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …

Identification of SARS-CoV-2 entry inhibitors among already approved drugs.

L Yang, RJ Pei, H Li, XN Ma, Y Zhou… - Acta Pharmacologica …, 2020 - europepmc.org
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …

Identification of SARS-CoV-2 entry inhibitors among already approved drugs

L Yang, RJ Pei, H Li, XN Ma, Y Zhou… - Acta …, 2021 - pubmed.ncbi.nlm.nih.gov
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …